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Abstract 
Coherent Anti-Stokes Raman Scattering (CARS) has established itself as an imaging 
technique capable of providing video rate imaging of biological specimens through 
vibrational coherence of endogenous molecules. Current techniques predominantly involve 
the application of costly, invasive and potentially non-specific dyes or labels for imaging 
biomolecules. CARS microscopy can however provide a high resolution and non-invasive 
alternative for imaging biomolecules of interest without the need for exogenous labels. 
Here we provide an overview of CARS including the technique and common instrumentation 
as well as its applications in biomedical imaging. We discuss the major biomedical areas 
where CARS has been applied such as in evaluating liver disease, progression of 
atherosclerosis, tumour classification and tracking drug delivery whilst also assessing the 
future challenges for clinical translation.     
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21.0 Introduction 
For over 300 years optical microscopy has been one of the fundamental tools to study biology (1-3). 
In addition to the traditional bright-field visualization, many developments in microscopy have taken 
place over the years. Of particular note are phase contrast (4) and differential interference contrast 
(DIC) (5, 6) microscopy. While the former utilizes an optical mechanism (phase plate introduced in 
the focal plane of a microscope) to extract phase changes, the latter implements an interferometry 
configuration (separating and recombining beams using a Wollaston prism) to translate the 
differential response (optical path-length differences) into images. Both the techniques enable 
visualization of otherwise transparent objects on biological specimens without the need for stains or 
labels, however, they only give architectural information.  
Staining (with dyes which can be fluorescent or non-fluorescent) has remained one of the main ways 
of molecular visualization and diagnostic imaging of cells ever since the first use of dyes in the mid-
nineteenth century (7). The discovery of the green fluorescent protein (GFP) (8-10) and its variously 
coloured analogues (11) together with the evolution of molecular biology techniques which enabled 
their endogenous expression as labels in fusion constructs with proteins of interest changed the 
landscape of molecular imaging in cells. Much of the current understanding in cellular biology is 
owed to the remarkable success of these strategies coupled with fluorescence microscopy.   
The foundation of fluorescence microscopy is the spectroscopy of the fluorochromes (fluorescent 
dyes, proteins and inorganic fluorophores) for visualising molecular processes in biology. Although 
fluorescence microscopy is widely used for detecting and imaging various biomolecules, it has one 
fundamental disadvantage: fluorochromes need to be attached or adsorbed on to them in order to 
be imaged (12). Therefore the success with fluorescence imaging relies heavily on the efficiency of 
the labelling or staining process. Expression of endogenous labelled proteins involves genetic 
modification of cells and arduous procedures sometimes involving a lot of trial and error. Moreover, 
whether the label modifies the functionality of the original molecule or affects other biochemical 
processes inside cells remains largely unknown.  Fluorochromes used in staining are primarily used 
post-fixation although few live-cell stains are also available. Use of natural dyes is much preferred in 
staining solutions as some of the synthetic dyes can be hazardous (8) besides the fact that 
nonspecific binding is a significant issue with fluorescent stains especially for imaging small 
molecules such as drugs, metabolites and lipids (13). Additionally such small molecules although 
extremely important for a variety of biochemical processes in cells and tissues are difficult to be 
3labelled without loss of function. Therefore a complimentary technique to fluorescence microscopy 
is highly desirable. Vibrational spectroscopy provides an alternative. Rather than using extraneously 
added fluorochromes, vibrational imaging generates contrast based on the intrinsic vibrations of 
molecules in their natural state inside the cell.   
In vibrational imaging, molecular bonds with a certain characteristic resonance frequency are 
probed. Each molecule, due to its variety of distinct vibrational modes possesses a unique 'finger-
print' spectrum allowing its identification. Infrared (IR) absorption spectroscopy and Raman 
scattering are the most common techniques used to characterize chemicals and materials using their 
vibrational finger-print. While in IR spectroscopy micrometre radiation is used to directly excite 
molecular vibrations, in Raman spectroscopy, ultra-violet (UV), visible or near-IR radiation is used to 
observe scattering mediated by molecular vibrations. The inelastic interaction of a photon with a 
vibrational bond is referred to as Raman scattering (Fig. 1).  Imaging with UV, visible or near-IR 
radiation results in better optical resolution than with IR. Moreover, crucially, IR spectroscopy is 
extremely sensitive to water which tends to obscure signals and limits penetration in biological 
specimens (14) unless samples are prepared carefully (dehydrated).  However, water is a weak 
Raman scatterer and therefore Raman scattering is more suited to biomedical imaging.  
Spontaneous Raman scattering can occur in two ways as shown in Figure 1:  the transition can 
originate either from the vibrational ground state and generate a red shifted Stokes Raman photon 
(Fig. 1A) or from an excited vibration level leading to a blue shifted anti-Stokes Raman photon (Fig. 
1B). Being a spontaneous process the intensity of the scattered radiation scales linearly with the 
power of the incident beam and the cross section of the process. The absolute Raman cross sections 
are typically in the range of 10-26 to 10-30 cm2 molecule-1 (15) thus around 6-10 orders of magnitude 
smaller than that of fluorescence. Thus Raman spectroscopy although powerful due to its inherent 
molecular characterisation and identification ability, non-invasive, non-destructive and label-free 
nature, is limited in applications especially in imaging due to its weakness.  
Fortunately, weak Raman signals can be amplified by four wave mixing processes. In 1963 Minck  et 
al. reported the generation of radiation at other frequencies due to a fourth-order process by 
focusing a Ruby laser in a cell filled with H2 atoms (16). It became clear that the lines of this radiation 
were dependent on vibrational-rotational transitions of the molecules. These processes are together 
referred to as nonlinear Raman scattering. The most prominent representatives are coherent anti-
Stokes Raman scattering (CARS) and stimulated Raman scattering (SRS).  In this review we focus on 
CARS and give an overview of its theory, technical and instrumentation aspects and detail the main 
areas in biomedicine to which CARS has been applied and is beginning to have an impact. In recent 
years there have been other reviews which cover CARS theory and its applications 
exemplify the exciting and expanding horizon of label
referred to for further details.  
2.0 CARS theory 
CARS bio-imaging was initially developed in 1982 where onion skin cells were studied by Duncan 
al. (20) and saw a revival since 
solid state lasers (21-23). Due to the massive enhancement of the Raman cross section in CARS and 
SRS, acquisition times comparable to those of fluorescence micro
These developments in sensitivity
with these techniques (25, 26).
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5In CARS, two pump photons and a Stokes photon interact simultaneously, mediated by a change in 
the third order polarisability, P(χ(3) ), of the molecule generating an anti-Stokes photon (ωas) at ωas = 
2 ωp – ωs. Due to the stimulated nature of this effect, all molecular polarisations oscillate 
coherently, leading to a strong amplification of the signal compared to spontaneous Raman. Being a 
third order non-linear process, the CARS intensity is dependent on the cube of the pump and Stokes 
beams’ initial intensities.    	
	  
Due to its coherence, CARS is also proportional to the square of the Raman active molecules N inside 
the focus.  Therefore, high contrast is generated when CARS-active molecules are present inside cells 
in high local concentrations.  
2.1 Non resonant CARS Background 
A major drawback of CARS is the non-resonant background generated simultaneously. Although 
CARS conversion is very efficient if the difference frequency ωp - ωs equals the vibrational resonance 
frequency (Raman shift) of a chemical bond, it also takes place under non-resonant conditions 
(Figure 1D). Instead of real vibrational Eigen states, electronic virtual states mediate the generation 
of a CARS photon.  In general, the CARS third order susceptibility is expressed as a sum of a resonant 
frequency dependent part and a frequency independent non-resonant part (nr):     
In case the difference frequency ωp – ωs does not match the frequency of a vibrational bond, the 
non-resonant contribution will dominate the CARS emission. The non-resonant part is present under 
all imaging conditions and therefore affects the sensitivity of the measurement. 
2.2 Other multi-photon effects 
The popularity of single photon fluorescence has accelerated the development of multi-photon 
fluorescence, where the energy of a single near infrared photon is not sufficient on its own to excite 
an electronic transition in the molecule. However, two simultaneously absorbed photons allow for 
this excitation to take place (figure 1E).  Due to the strong non-linear origin of multi-photon 
processes, excitation is restricted to the femtolitre sized volume at the microscope focus. Ultimately 
this reduces photo bleaching and enhances the spatial resolution of all multi-photon processes 
including CARS 1): All multi photon microscopes exhibit inherent confocality. Unlike single photon 
fluorescence, multi-photon processes allow deep optical penetration such as investigations of 
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(27). Another highly important non-linear process, also label-free, is second harmonic generation 
(SHG) generated in biological media giving insight into the extra cellular environment of tissues by 
detection of mostly collagen (28). Mediated by the second order polarisation, two photons incident 
at a non-centrosymmetric structure are converted into one photon with doubled energy, hence 
frequency. Both two-photon excitation fluorescence (TPEF) and SHG can easily be combined with 
current CARS setups since all techniques rely on similar laser technology. CARS, TPE and SHG 
emission often occur in well separated spectral regions and can easily be distinguished with 
appropriate filters.  
3.0 Technical and instrumentation aspects in CARS 
3.1 Laser sources and imaging 
The strong non-linear nature of Raman processes in CARS requires sophisticated laser systems to 
provide two pulsed laser beams ωp and ωs (Fig. 1c) with high peak powers. Intuitively, shorter pulse 
durations give higher signals based on probability of higher order mixing processes. However, for 
CARS and SRS which rely on molecular vibrational transitions this is not the case. Typical Raman line 
widths (~10 cm-1) are comparable to the spectral width of pulses with a couple of ps temporal 
duration. Numerical simulations show that the intensity based on the resonant part of the 
susceptibility saturates with shorter pulse durations (22). The non-resonant contribution however, 
has a quadratic dependence on the pulse duration. In the femtosecond regime, shorter pulses 
therefore generate a larger non-resonant contribution.   
Many CARS (22) and SRS (29, 30) setups hence do not use the whole spectral width of a fs laser pulse 
for a pump or Stokes beam. For optimal spectral resolution ps pulses (~7 ps, 3 cm-1) have been 
recommended (31).  Other groups are able to address long coherent times (ps range) of Raman 
resonances using fs pulses by shaping the spectrum of their temporal interference (32). This 
technique excites CARS processes efficiently by applying a linear chirp to both pulsed beams through 
glass dispersion.  
 Two main approaches for generating the two necessary laser beams have been developed: 1) 
Systems which utilize two separate lasers or a configuration of a laser and an optical parametric 
oscillator (OPO) and 2) Single laser and fibre based systems. 
 
73.1.1 CARS microscopes with two independently tuneable lasers
Titanium:Sapphire (Ti:Sa) lasers are tuneable over a wide range (650 nm-1050 nm) and can be used 
in the picosecond configuration. The two lasers can be tuned into most Raman resonances from 
small shifts of several hundred wavenumbers up to the CH2 stretching region (2800-3000 cm
-1) – a
huge advantage compared to other approaches (33).  Both lasers have to be synchronised in time for 
a constant phase relation of the pulses (34). In a different approach, Mueller and Cheng et al. (35-37)
and more recently Day et al. accomplished CARS microspectroscopy by using narrowband (10 ps, 
Spectra Physics Tsunami) and a broadband laser source (second Tsunami laser at 80 fs); this allowed 
acquisition of vibrational spectra over a 400 cm-1 bandwidth while scanning a sample (38).   
 
3.1.2 OPO based CARS microscopes
Two lasers are not particularly cost effective and therefore most CARS setups use a single laser 
source which is split into two beams.  One beam serves as the pump beam and the second is 
converted into either pump or Stokes beam by optical parametric conversion. OPOs are tunable over 
a wide range of wavelengths (39) and generate two beams (called the signal and idler) at lower 
frequencies such that their combined energy (of the 2 photons, respectively) equals that of the 
pump laser. A limitation of the Ti:Sa laser pumped OPOs (21, 22, 40) is the gap between laser pump 
and signal wavelengths because of which Raman shifts  below 2400 cm-1 are difficult to be imaged.  
Nevertheless, these high power OPOs are desirable for high speed video-rate imaging which keep 
pixel dwell times low.  A lot of current setups use frequency doubled solid lasers at 532nm pumping 
OPOs tuneable between 680 nm and 2150 nm (Levante Emerald, PicoEmerald, APE, Berlin) (25, 31, 
41-43). In the latter case the output beam then serves as the tunable pump beam at a lower 
wavelength than the laser (Stokes) wavelength which is usually the fundamental laser wavelength of 
the solid state (e.g. Neodymium) laser at 1064 nm. Freudiger et al. achieved powers of <40mW in 
both beams (31) which such a system, sufficient for fast CARS and SRS imaging. This OPO setup is 
shown in figure 2A. Current CARS systems may even have the laser, SHG unit and OPO built in the 
same system. Compact systems like the “picoEmerald” from APE Berlin deliver the two necessary 
beams and tune through almost all Raman shifts important for CARS imaging (700-4500cm-1) in a 
fully automated manner. While these systems remain expensive, Zhang et al. showed that it is 
possible to successfully perform CARS imaging with an OPO built from scratch (40). 
Figure 2. (A) Schematic of an OPO based laser system based on commercially available, tunable
parametric oscillator (OPO) from APE pumped by a frequency doubled (SHG, second harmonic generation) 
ND:YVO4 laser. The system allows multichannel detection of TPE, SHG and CARS signals. For CARS signal 
generation, (OPO) pump beam and the ND:YVO
by means of a delay stage (DL). (B) C
at 2900 cm-1(b) corresponding to a C
peaks of the dispersive line shape in (a). 
from ref. (44). Reproduced with permission. (
programmable laser (PL) and a master oscillator (MOPA) serving as pump and Stokes sources. This system is 
based on high frequency, highly versatile function generator consisting of a digital synthesiser and a pulse 
generator driving electro optical modulators (EOMs).  The delay of both pulses can be matched electronically. 
Frequency tuning is accomplished by varying the repetition frequency of pulses circulating in an Erbium fiber 
which changes the effective pulse dispersion in a chirped fiber Bra
diodes complete the setup. Image from ref. 
4 fundamental serving as Stokes have to be temporally overlaid 
ARS micro-spectroscopy performed by  Okuno et al. showing a CARS image 
-H stretching bond taken by mapping the intensity d
This CARS spectrum corresponds to a position inside
C) State-of-the-art fiber based CARS laser system 
gg grating (CFBG). Amplifiers (AMP) and 
(45). Reproduced with permission.  
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93.1.3 Single laser and fibre based laser sources for CARS 
It is possible to use a single ultra-short pulsed laser (<10 fs) with a broad spectrum and pick Stokes
and pump wavelengths individually by filtering or adding chirp (32, 46, 47). In this latter approach the
laser beam is split into lower and higher wavelength portions and care is taken to adjust the chirp of
both pulses so that their instantaneous frequency difference remains constant. Changing the delay
alters the instantaneous frequency difference and hence the Raman shift. Other approaches commonly
implemented, due to their relative inexpensiveness compared to two laser/OPO systems, with fibres
are described below.
a) Super continuum based hyperspectral imaging 
Despite automated tuning, multicolour imaging by tuning OPOs is slow. Lim et al. report that their 
systems requires 20 minutes for a hyperspectral image stack to be generated (48). An easier 
approach towards multicolour and hyperspectral imaging is implemented by using instead of an OPO 
(in the scheme shown in Fig 2A) a continuum fibre (49-52) or even plain sapphire crystals (29, 30) to 
generate a continuum of Stokes wavelengths. With a typical continuum fibre, Stokes photons 
between 830 nm and 1100 nm are generated and thus can excite all possible CARS transitions of a 
molecule simultaneously. This broadband CARS approach allows taking a single spectrum within a 
few tens of milliseconds. An interesting hyperspectral CARS setup combined with a time resolved 
excitation scheme was published by Selm et al. By carefully adjusting the temporal delay of the 
excitation pulses and tailoring their shape, the non-resonant contribution of the CARS signal can be 
suppressed (53).  Many designers of continuum fibre based systems claim that these fibres are 
perfect for applying them in nonlinear Raman imaging setups because of their wide spectrum (54). 
However, the overall power generated by continuum fiber is an integral over the whole spectrum. 
The power of a line of the spectrum is therefore small compared to that from an OPO and often too 
weak for fast imaging.  
 
b) Single line fibre based CARS systems 
A recent technological innovation for fast wavelength swept CARS hyperspectral imaging was 
introduced by Bégin et al. (45) A fibre based pump laser is combined with a fast, tunable 
programmable laser allowing up to 10000 flawless wavelength changes per second (45). In contrast 
to passive OPO systems, all parameters including pulse rate, wavelength, delay vs. the master 
oscillator are controlled by a high performance function generator which is programmed via 
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software. A sketch of the laser design is shown in figure 2C. The main limitation is the current 
available range of Raman shifts between 2700 and 2950 cm-1 only. However, the system is very 
flexible and can be used for imaging as well as generation of CARS spectra. 
 
Pegoraro et al. developed a solution based on a single fibre based pump source at 820 nm and a 
highly non-linear fibre.  One of the red shifted solitons generated inside the fibre was picked by a 
filter and its wavelength tuned by varying the input power (55). An all fibre based system has been 
shown by Baumgartl et al. who use a Ytterbium (Yb) tunable fibre laser generating 100 ps pulses 
which are converted to a wavelength pair at 780 nm and 1030 nm with ~40 ps pulse duration using a 
PCF (56). Unfortunately only CARS with Raman shifts around 3000 cm-1 is demonstrated but it should 
be possible to reach 2900 cm-1 after slight changes in their configuration. The same group 
demonstrates a second laser system which is a highly integrated all fibre system consisting of an Yb 
ps oscillator, however doesn’t allow tuning through different Raman shifts. The fibre needs to be 
tailored for a specific pump frequency at a specified output (57).  An interesting approach is 
presented by Gambetta et al. A femtosecond Erbium (Eb) based fibre oscillator is spectrally focussed 
and frequency doubled. A second portion is coupled into a super continuum generating fibre and its 
long wavelength peak compressed and doubled. Raman shifts from 300 cm-1 to 1000 cm-1 can be 
addressed. Wavelength tuning is accomplished by heating PPLN crystals (54).    
 
3.2 Suppressing the nonresonant background 
The non-resonant contribution increases quadratically with decreasing pulse width and hence, ps 
lasers sources are preferable for less non-resonant background generation. Further spectral pulse 
narrowing below the Raman line width of 10 cm-1 (24) however, decreases the signal for the same 
level of background signal.  Epi-detection (58, 59) and the use of a collinear beam geometry (21)
have been shown to be beneficial. A popular background suppression technique relies on different 
polarisation properties of the resonant and nonresonant parts of the third order susceptibility (see 
equation 1). The nonresonant susceptibility is a real quantity in the system and independent of the 
Raman shift. The non-resonant CARS signal is linearly polarized. A polarizer which is placed 
perpendicular to that angle reduces the background very efficiently (52, 60). 
3.2.1 Heterodyne, interferometric and differential CARS 
Both Heterodyne and interferometric CARS distinguish between the resonant and non-resonant 
terms by mixing the CARS signal with a reference field from a local oscillator. The result is then 
11 
 
dependent on the phase difference Φ between the CARS and the reference field, an interferometric 
mixing term. It is well known that the imaginary part of the CARS susceptibility contains the resonant 
information (61), hence is proportional to the signal in a spontaneous Raman spectrum.  In 
heterodyne CARS, the phase difference Φ introduced by Im(χ) is usually probed by phase modulating 
the reference field and evaluating the resulting amplitude modulation after interference of both 
beams although modulation of the pump beam itself can also be carried out, which results in twice 
the modulation of the detected CARS frequencies. A lock-in amplifier is then used to evaluate the 
detected signal and extract the resonant part (62-64). The implementation is slightly more involved 
but the background suppression is efficient. In contrast to heterodyne CARS, in spectral 
interferometric CARS the necessary phase information is calculated from the spectral interference of 
a broadband reference CARS signal with the sample signal. Other variations of interferometry to 
remove the background have also been implemented such as in Fourier transform CARS (65). 
In differential CARS, the same linear chirp to both pump and Stokes beams is added (32). This allows 
an effective instantaneous frequency difference (IFD) to be maintained between the chirped pump 
and Stokes beams. A different IFD can be addressed by tuning the delay between the beams. By 
generating two pulse pairs each exciting a different IFD, the resulting CARS intensities can be 
detected simultaneously by a single photomultiplier as sum and difference using phase-sensitive 
frequency filtering. The CARS intensities of both beams I1 and I2 are adjusted so that the differential 
CARS (D-CARS) signal is non-existent in the surrounding solution of a Raman active medium. Thus 
this also results in signals which are virtually background free (66).    
3.3 Detection  
3.3.1 Epi and forward detection 
Unlike isotropic fluorescence, CARS and SRS radiation pattern depend on shape and size of the 
scattering object. According to Cheng et al. rod-shaped large objects, compared to the pump 
wavelength produce a cone of CARS radiation in forward direction whereas small, disk-sized objects 
generate both a forward and backward signal (22, 24). In the latter case, it is better to use epi-
detection since the non-resonant background from the surrounding medium radiates mainly in 
forward direction (22, 34) . Most CARS setups have forward and backward detection installed and 
make use of multichannel detection to exploit all available information delivered by CARS. 
Hyperspectral CARS setups have to use a CCD detector in addition to a spectrograph in order to 
generate spectra. PMT sensitivities are better than those of CCD arrays at high scanning speeds of 
individual pixels (67). For ultrafast imaging, PMT based detection is vital to keep pixel dwell times 
low, alternatively, avalanche diodes (APDs) can be used. PMTs are useful for laser scanning owing to 
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their large active area. Multicolour detection of CARS in combination with SHG and TPE can easily be 
implemented using appropriate dichroic long-pass and band-pass filters. Instantaneous sampling of 
modern data acquisition cards enables live observations using multiple photodetectors. 
4. CARS applications in biomedical imaging 
Within the biomedical field, spontaneous Raman spectroscopy has been extensively used to classify 
many diseases and identify potential markers of progression (68, 69), it has proven to be a highly 
valued tool for its label-free diagnostic potential (70) especially within the cancer field for its high 
accuracy classification of multiple types of tumour (71, 72) . However, due to its low sensitivity, 
imaging requires long acquisition times per pixel in a raster scan fashion, these conditions are not 
ideal for use in biomedical applications such as live cell or in-vivo imaging. (72, 73). In contrast, CARS 
allows acquisition of 3D images down to depths of 400 µm at video rate acquisition times, which is 
much more amenable to live cell imaging (18, 74, 75). As described in the previous section extensive 
developments have taken place over the last decade in CARS technology improving its 
implementation and capabilities. CARS is increasingly recognized as a mature technique and 
therefore has rapidly growing applications in biomedicine. Moreover, the possibility of 
simultaneously implementing SHG and TPE on the same microscopy setup offers multimodality 
much suited to molecular imaging in cells and tissues. Some typical CARS systems and their 
applications in imaging different biochemicals are summarized in Table 1.  
Table 1. Overview of commonly used CARS systems for imaging of biochemicals in cells and tissues 
Excitation 
source 
OPO (nm) Pump and Stokes 
wavelength (nm) 
Wavenumber 
(cm-1)
Biochemical Biological 
Application 
1064nm, 7ps, 
Nd:YVO4 laser 
(High-Q Laser) 
680-980 
(APE) 
 
817 and 1064 2845 Lipid
(CH2)
Cancer (76, 77)
1064nm, 7ps, 
Nd:YVO4 laser 
(High-Q Laser) 
 
680-980 
(APE) 
 
953 and 1064 1095 DNA
(PO2)
Nuclei 
Morphology 
(78, 79)
1064nm, 7ps, 
Nd:YVO4 laser 
(High-Q Laser) 
817 and 1064 2845 Lipid
(CH2)
Atherosclerosis 
(80); Lipid 
metabolism in 
worms (C. 
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elegans)(81)
1064nm, 6ps, 
Nd:YVO4 laser 
(High-Q Laser) 
680-980 
(APE) 
 
811 and 1064 2930 Protein
(CH2)
Cell Apoptosis 
(82)
700 – 1000nm, 
100fs, Ti:Sa 
laser (Mira 900, 
Coherent) 
700-1600 
(APE) 
 
835 and 1095 2845 Lipid
(CH2)
Liver Steatosis 
(83)
As CARS sensitivity depends on the square root of the concentration of the vibrational modes, a 
concentration of 105 to 106 vibrational oscillators in the focal volume is required to provide adequate 
contrast for imaging (84), thus biomolecules with the strongest Raman signals and large local 
concentrations are most suited to imaging. Lipid biomolecules are highly abundant in C-H chemical 
bonds and therefore provide high image contrast in living organisms; it is for this reason that they 
are the most widely studied for label free imaging using high resolution CARS microscopy (17, 85). 
Some examples of imaging liver and skin using multimodal non-linear imaging are shown in Figure 3. 
CARS in combination with other NLO imaging modalities has been utilised recently in many 
biomedical studies evaluating steatosis and fibrosis in liver (83, 86), progression of atherosclerosis in 
cardiac disease (80, 87), demyelination of the central nervous system (CNS) (88, 89), cancer 
classification (77, 90) and assessing the pharmacodynamics, delivery  and efficiency of therapeutic 
drugs (91, 92). In subsequent sections we describe CARS studies in various biomedical areas. 
 
Figure 3. Non-linear optical imaging of biological 
CARS (red) and TPEF (blue) imaging of skin sebaceous glands illustrating sebum rich compartments within cells. 
The right hand corner image confirms presence of nuclei in cell areas devoid
staining. (C) CARS (red) and SHG (blue) imaging of 
matrix. (D) CARS (red), SHG (blue) and autofluorescence (green) imaging of skin tissue illustrating 
sebocytes/epidermis, collagen and hair shafts, respectively. 
with an OPO based CARS system described in 
4.1 In-vivo imaging of skin 
The skin is the largest organ in the body acting primarily as a protective barrier against chemical, 
physical and pathological insults. It can be divided into three main layers of epidermis, dermis and 
subcutis, interspersed with hair follicles, sebaceous 
the avascular, outermost layer of the skin compr
keratinocytes (>90 % cells), melanocytes, Langerhans cells and Merkel cells (mechanoreceptors). It 
can be subdivided into the following layers: 
tissues (z-stacks). (A) CARS imaging of lipid rich liver tissue. (
of lipids through Hoechst 33342 
pancreatic adipocytes illustrating an outer collagenous 
These images from our la
(93).  
glands and sweat glands (9
ising several epithelial-
stratum corneum, stratum granulosum
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B)
b have been acquired 
4). The epidermis is 
cell types including 
, stratum 
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spinosum and stratum basale averaging 60-70 µm in thickness in normal healthy skin (95, 96). 
Disorders, conditions and diseases of the skin can vary tremendously from alopecia, acne and 
psoriasis to malignant cancers, many of which commonly require the application of topical 
ointments to alleviate or treat the symptoms.      
 
As the outer most surface of the body, skin is the most ideal tissue for live in vivo analysis. By 
demonstrating the strong epi-CARS signal backscattered from tissue, Evans et al. paved the way for 
CARS imaging by illustrating video-rate in vivo imaging of lipid (CH2) rich structures such as 
adipocytes, sebaceous glands and corneocytes within the skin (25). By applying oil to the skin, the 
potential to track chemicals and their penetration was also shown to be feasible. In one of the first 
studies on clinical samples, CARS imaging visualised the distribution of topical ointment of omega-3-
oil over a specific time period by comparison of CARS images at 2845 cm-1 (lipids) and 3295 cm-1 
(water). It illustrated that the oil entered through microscopic skin folds and accumulated at skin 
fold boundaries (97). In another study, Zimmerley et al. determined that d-glycine and water 
distributes homogenously through cortical regions of the follicular hair (98).  Whilst more recently, 
imaging of healthy skin in comparison to psoriatic skin found differential lipid distributions at the 
stratum corneum making CARS imaging a valuable tool for providing insight into disease mechanisms 
(99). CARS imaging with regards to the skin has gained great interest as an in vivo approach to track 
the penetration of topical ointments and drugs. It is for this reason that CARS imaging would appeal 
widely to the pharmaceutical industry to assess the pharmacokinetics and penetration capabilities of 
cosmetic skin care products, ointments or drug over long term studies in vivo (100).               
 
4.2 Assessing atherosclerosis    
Atherosclerosis is a complex and progressive disease which involves the accumulation of lipids and 
cholesterol within the arterial walls. This multi-stage process involves an inflammatory response in 
which macrophages extravasate into the arterial walls and phagocytose low density lipoproteins 
(LDLs). The LDLs are unable to be broken down by the macrophages leading to gathering of 
phenotypical foam cells. Accumulation of LDL ultimately leads to foam cell rupturing and further 
increased macrophage infiltration, causing continuous progression of disease (101). As lipids are vital 
components of the atherogenesis process its morphology, composition and quantitation in plaque 
formation are fundamental to gaining new insights into cardiac disease (102, 103). Current clinical 
diagnostic techniques involve non-invasive methods such as computerised tomography and 
magnetic resonance imaging which require contrast agents and have low resolution hindering the 
capability to detect early stages of atherogenesis (104).  
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CARS imaging is capable of providing mechanistic information in a label-free manner at a sub-
cellular, cellular and tissue level without the requirement of contrast agents. Several studies have 
therefore employed multiplex CARS and associated multiphoton imaging techniques for the further 
elucidation of atherosclerotic plaque formation. Ko et al. illustrated the application of CARS to image 
atherosclerotic plaques (Fig. 4) in myocardial infarction prone rabbits (105). In a diet based study, 
Lim et al. characterised the effect of varied fat intake on early stage II/III plaque formation in ApoE-/- 
mice using SHG to determine collagen content, TPEF to determine elastin fibers and CARS imaging 
for lipids (106). Westernised diets (high fat, high cholesterol) illustrated a 2 fold increase in arterial 
plaque area in comparison to a low fat standard diet. High magnification CARS images also 
illustrated clearly defined macrophages with distinct nuclei and lipid rich cytoplasm, additionally 
verified by CD68 macrophage staining. Interestingly, SHG identified a 4-fold decrease in collagen 
distribution in western diet plaques, potentially caused by macrophage induction and matrix 
metalloproteinases (106, 107). Further studies using hyperspectral CARS imaging not only identified 
lipid rich macrophages but also allowed distinction of lipid structure types such as needle and 
platelet shaped cholesterol crystals (48). Cholesterol crystals in plaques were evident with a 
significantly greater contribution in wild-type than in ApoE-/- knockout mice, suggesting a potential 
role of ApoE-/- in cholesterol crystal inhibition. Through compilation of the previous CARS based 
evidence, Kim et al. quantified 4 representative types of atherosclerotic lipids of needle and platelet 
shaped cholesterol crystals, extracellular lipid deposits and lipid foam cells in different stages of 
atherosclerosis (80). Lipid foam cells and extracellular lipids were present throughout each stage 
with significantly increased amounts of lipids at each stage; needle/platelet shaped cholesterol 
crystals were only present in advanced stages in the lesser curvature of aortic arch and innominate 
artery. Using CARS Duewell et al. implicated cholesterol crystals to have an effect on the plaque 
rupture susceptibility with its various forms and also presented evidence indicating its potential to 
activate macrophages through NLRP3 inflammasome (102). 
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Figure 4. Representative epi-NLO images collected from healthy arterial lumen on A) 4-month-old and B) 10-
month-old atherosclerosis-induced myocardial infarction prone Watanabe heritable hyperlipidemic (WHHLMI) 
rabbit using 20x air objective lens, and on a 4-month-old rabbit using 40x WI lens at C) lumen surface and D) 
~20 µm depth from surface. Representative epi-NLO images of arterial lumen surface obtained from E) an 
early atherosclerotic lesion and F) an advanced atherosclerotic lesion using 20x air lens. Green:TPEF elastin or 
other fluorescent particles. Blue:SHG collagen. Red:CARS lipid-rich structure. Image from reference (105).  
Published with permission. 
 
4.3 Diagnosis of liver disease 
The liver is a central organ for metabolic homeostasis whilst also playing a major role in 
detoxification. Biochemical pathways of gluconeogenesis, lipogenesis and cholesterol metabolism 
are constantly occurring making the liver a vital site for the synthesis, metabolism, storage and 
translocation of proteins, lipids and carbohydrates (108). Metabolic syndrome and obesity causes 
alteration in these metabolic pathways which can lead to pathophysiological changes within the liver 
known as non-alcoholic fatty liver disease (NAFLD) which can ultimately lead to hepatocellular 
carcinoma (109). Hepatic steatosis, abnormal accumulation of lipids, is an early stage sign for the 
diagnosis NAFLD or hepato-toxicity resulting from the accumulation of lipids in liver tissue. Current 
gold standard techniques to diagnose the severity of steatosis are carried out through 
histopathology from excised tissue sections (110). Inaccuracies in clinical diagnosis can occur 
through chemical processing of tissue using xylene which inevitably removes lipids from sections, 
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whilst use of the ORO stain can also result in overestimation of steatosis as this is not specific to lipid 
droplets (111, 112).    
 
Several studies have highlighted the use of CARS as a label free approach to provide improved 
accuracy and early diagnosis through taking advantage of its ability to image lipids without 
exogenous labels. Using a multimodal imaging system Lin et al. explored the fibrosis and steatosis 
effects of bile duct ligated rats (83). As a result, significant accumulation upto week 4 of lipid 
droplets was identified by CARS, whereas increased collagen fibrils upto week 6 was identified by 
SHG in association with severe hepatocyte necrosis. These findings demonstrate that there are 
potential differential rates of development for steatosis and fibrosis in NAFLD. More recently, Le et
al. induced hepatotoxicity by feeding wild type and transgenic mice with fenofibrate (a common 
drug) to impair mitochondrial function and induce pathological onset of microvesicular steatosis. 
This study showed that CARS analysis on unstained sections had increased sensitivity to steatosis not 
only for severe cases but also for mild cases (see figure 5). On the contrary, ORO stained tissue 
sections were only sensitive to severe cases of steatosis (86). 
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Figure 5. Detection of hepatic microvesicular steatosis with ORO histology and CARS microscopy. 
Representative ORO histology images (left column), CARS images (middle column), and surface plots of CARS 
images (right column) for wildtype mice with no steatosis (upper row), UPase-TG mice with mild 
microvesicular steatosis (middle row), and wildtype mice fed with 400 mg/kg/day fenofibrate for 5 days with 
severe microvesicular steatosis (lower row). Three mice, thus 3 livers, per animal group were used for direct 
comparison of ORO histology and CARS imaging analysis of microvesicular steatosis. Surface plots were 
performed with ImageJ software.  Image from reference (86). Reproduced with permission. 
 
4.4 Classifying cancer and mechanisms of invasion 
4.4.1 Cancer classification 
Turnaround times for cancer diagnosis and classification is pivotal towards the prognosis of the 
disease and the therapeutic treatment provided. Currently the gold standard clinical diagnostic test 
for cancer classification is surgical excision and conventional histopathological analysis, a procedure 
which has long turnaround times of a few days. If insufficient material has been retrieved or a 
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tumour free margin has not been obtained, repeat surgery is required which is time consuming and 
expensive (113). Alternatively, a mis-diagnosis could lead to unnecessary or postponed treatment for 
the patient. Several studies have utilised CARS imaging for cancer diagnosis which can provide a 
rapid histological diagnosis (76, 77). 
 
Through exploitation of CARS contrast for lipid distribution (2845 cm-1) in cells, morphological 
identification of the cell nuclei is also possible due to predominance of compact DNA instead of lipids 
in them; therefore they show a lower concentration of C-H stretching intensities resulting in 
negative contrast in lipid distribution images. Yang et al. utilised this contrast to quantify 
morphological and geometrical information of cell nuclei using tessellation and triangulation 
analyses to distinguish breast cancers (76) as shown in Figure 6. Classification using multivariate 
techniques identified ratings for ductal against lobular carcinomas with up to 100% accuracy and up 
to 92% for benign to invasive cancers (76). Similar studies using the same quantification was further 
applied to lung and prostate tissue. In lung tissue, discrimination of normal from cancer lung tissue 
produced a 91% sensitivity and 92% specificity rate whereas, remarkably, small cell carcinomas were 
distinguished from non-small cell carcinomas with 100% sensitivity and specificity (77). Gao et al. 
also identified significant discrimination (P  0.01) of normal from cancerous prostate tissue. 
Together, these studies illustrate the consistently high classification rate of cancer types without the 
requirement of long tissue processing procedures. Further justification of its potential as a 
histological diagnostic tool would require high classification of the hundreds of cancer types, a role 
currently carried out by a histopathologist. 
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Figure 6. A CARS image (A) from the Z-stacks of an IDC sample, showing cell nuclei segmentation (B), Voronoi 
tessellation (C), and Delaunay triangulation (D). These analyses allowed differential diagnosis breast cancer 
sub-types. Image size: 120 x 120 μm2. Image from reference (76). Reproduced with permission.    
 
As also described later in section 3.5, the role of CARS for imaging myelin in neurones has been well 
documented. In a study imaging the prostate, the presence of cavernous nerve bundle fibres could 
clearly be identified from its lipid-rich myelin (114). As radical prostatectomy for prostate cancer can 
sometimes cause erectile dysfunction due to damaging cavernous nerves, prognosis of surgery could 
be greatly improved with intra-operative applications and development of CARS laparoscopy. Meyer 
et al. carried out a study imaging lung metastases to the brain, as the biochemical information of the 
primary tumour differs remarkably to that of the brain; this allowed CARS tumour margin 
identification using the homogenous and delineated area of the primary tumour using CARS at 2845 
cm-1. Additionally, individual tumour islets of homogenous dense tumour cells were also 
distinguishable in comparison to the heterogeneous brain tissue (115). With the advancement in 
technology for application of fibre optic CARS, it would be feasible that this high classification rate of 
cancers and delineation of tumour margins could also be applied surgically in-vivo, whilst also 
alleviating potential risks and side effects of surgery. 
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4.4.2 Insight into mechanisms of tumour invasion and metastases 
Understanding the mechanistic roles of cancer progression and invasion is essential for the 
development of rapid diagnostic tests and therapeutic treatments. It has been established that 
obesity and a high fat diet can enhance cancer metastases within the body as excess lipids can 
aggravate cancer (116, 117). Using the novel imaging capabilities of CARS and other NLO techniques, 
one can provide novel insights into the dynamics and mechanisms of cancer invasion. 
 
A study using Balb/c cancer model mice fed on a high fat and lean diet were investigated for lipid 
effects in cancer development and progression (118). Using CARS imaging it was found that primary 
tumours in mouse models were unaffected by high lipid diet. However, two weeks after tumour 
implantation, high fat diet mice significantly induced circulating tumour cells. CARS and TPEF imaging 
in combination with intravital flow cytometry of mouse ear vein allowed identification of these 
circulating tumour cells containing high lipid content. The induction and promotion to metastatic 
cells could be attributed to free fatty acid incorporation in cancer cell membranes, reducing cell-cell 
contact and increasing surface adhesion (118, 119). Recently, as a clinical diagnostic technique 
metastatic circulating tumour cells in the blood were analysed for CARS signal intensity for 
intracellular lipids. A 7-fold increase in lipids was identified in metastatic cells compared to normal 
blood leukocytes providing a potential label-free biomarker for metastatic cancer (90). Mitra et al. 
additionally studied lipid mobilization of metastatic cells showing rapid lipid uptake and slow lipid 
mobilization kinetics in comparison to that of non-transformed RWPE-1 and non-malignant BPH-1 
prostate epithelial cells. This high lipid affinity of metastatic cells could be manipulated to increase 
CARS sensitivity for clinical diagnosis (90). 
 
Within tissue, the extracellular matrix plays an important role in homeostasis with many studies 
having identified its contribution to tumour progression and invasion (120). Current evidence 
indicates adipocytes have the role of an endocrine organ and potentially affect tumour progression 
(121). Epithelial-stromal interactions were imaged by CARS using mammary adipocytes of the fat 
pads or intraperitoneal adipose within a co-culture system for tumour cells. Unique findings of viable 
tumour cells present within epithelial-free fat pads concur with adipose as a maintenance factor of 
tumour cells whilst adipose tissue excised from different anatomical locations showed varied 
distinctive patterns of promoting tumour cell growth (122). From these studies, we can conclude 
that CARS has illustrated that the contents of the cellular microenvironment including lipids play a 
pivotal role in propagating invasion and metastases. Thus CARS can become an important tool for 
elucidating lipid related mechanisms in tumour cells. Moreover, development of a CARS flow 
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cytometer could allow diagnosis of early stage metastatic cancers from a simple blood test (123, 
124).                   
4.5 Myelination of the nervous system 
The myelin sheath is a multilayer membrane, which wraps axons in the nervous system to provide 
electrical insulation and enable high-speed impulse propagation along the fibre. The myelin 
membranes contain about 70% lipid by weight and the high-density CH2 groups produce a large 
CARS signal (125, 126). The first report of CARS microscopy to image the myelin sheath was in 
explanted spinal cord tissues illustrating the node of Ranvier (127). Demyelination can cause loss of 
signal conduction across axons, characteristic in central nervous system (CNS) disorders such as 
multiple sclerosis or spinal cord injuries. CARS provides a non-invasive and label-free platform for 
imaging de-myelination of neurones during disease and re-myelination during repair.  
 
Currently, CARS microscopy has been widely applied to label-free visualization of the myelin sheath 
in nerves from animal studies. From ex vivo tissue slices, mosaic images illustrating the presence of 
white matter in the cerebellum, fimbriae hippocampus  and corpus collusum have been all captured 
in a high contrast single image (89, 115). As the causes of paranodal myelin damage in neuronal 
injuries are still obscure, studies to identify the mechanistic effect of chemical compounds such as 
lysophosphatidylcholine and glutamate were carried out in live spinal cord tissues (88, 128). Such 
studies using CARS can maintain high contrast without using invasive, non-specific labels which can 
photobleach. Both glutamate and lysophosphatidylcholine were shown to cause myelin splitting and 
demyelination respectively through subsequent calcium signalling and activation of calpain (88, 128, 
129).  In a study carried out by Meyer et al. brain tumours were imaged using CARS at 2845 cm-1 for 
imaging lipids; areas of homogenous high lipid intensities identified delineated solid tumour regions 
which could be utilised for tumour margin identification in vivo (115). Unlike other microscopy and 
imaging techniques that require lengthy or fixed sample preparation, CARS imaging allows high 
resolution real-time imaging to shed light on the dynamic behaviour of myelin.   
4.6 Drug studies
4.6.1 Imaging drug effects on cellular metabolism  
Therapeutic drug interactions with cells initiate and alter biochemical signalling pathways leading to 
alterations of molecular moieties. An increased or decreased concentration of specific molecules in 
response to drug therapy in certain locations can produce CARS contrast which can be exploited by 
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CARS imaging. Its capability of tracking alterations of cellular metabolism and molecular organisation 
makes CARS an asset as a qualitative and quantitative imaging platform to determine drug efficiency 
(82).  
Recently, lipid droplet formation has been identified as an early marker of cell apoptosis (130). The 
induction of cellular apoptosis leads to an increase in mitochondrial membrane potential resulting in 
reactive oxygen species (ROS) formation. ROS inhibits the beta-oxidation of the fatty acyl-COA which 
normally leads to production of ATP. Instead, it is re-directed into lipid synthesis and lipid droplet 
formation. Thus the efficiency of chemotherapy drugs, which promote apoptosis, can be evaluated 
through the quantification of CARS active lipid droplet formation at various time points. We have 
demonstrated this cell based assay using three cancer drugs and show that campothecin and 
etoposide had similar chemotherapeutic effects while staurosporine a powerful drug induced higher 
levels of lipid droplet formation after 24 hours of incubation (93). This could potentially be through 
the activation of other mechanisms of apoptotic induction, warranting further investigation. In 
cardiovascular disease, statin therapy is the cornerstone treatment to alleviate symptoms by 
inhibiting the cholesterol biosynthesis pathway (91). Using multiplex CARS, various lipid types such 
as plate and needle shaped cholesterol crystals, lipid laden foam cells and extracellular lipids can be 
assessed in atherosclerosis. In ApoE -/- knockout mice, significant reduction of lipid accumulation 
after treatment with simvastatin was identified in intact atheromatous lesions, compared to that of 
non-treated mice (80). These studies indicate that multiplex CARS is an effective tool for pre-clinical 
drug screening and potentially in vivo assessment of chemotherapy treatments on tumours.        
4.6.2 Imaging for drug delivery and distribution 
Directly imaging unmodified drugs in cells requires a distinctive Raman peak signal stronger than the 
background from biochemicals in the cell. Due to the abundance of vibrational modes from different 
molecules in comparison to a single drug molecule, attaining such a peak could pose difficult 
especially in the Raman fingerprint region (72, 73). The spectral regions of 1800-2600 cm-1 are 
typically silent for most cellular biochemical constituents as only few specific moieties such as triple 
bonds, C-D vibrational modes have their peaks in this region and these are not normally present in 
cellular biomolecules. Therefore utilisation of molecules or Raman labels which have signals in this 
region can be exploited to track molecules using CARS. Deuterium commonly exploited by NMR 
spectroscopy has been used as a label in nanomedicines as the Raman peak of CH2 (2850 cm
-1) is 
shifted when deuterated to CD2 (2100 cm
-1) (131). A recent example is shown using deuterated 
Quaternary Ammonium Palmitoyl Glycol Chitosan (dGCPQ) particles of 30-50nm size which were 
tracked and pinpointed in mouse through the gastrointestinal tract, liver and gall bladder after oral 
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administration as shown in Figure 7 (92). Use of isotopic labels in conjunction with CARS imaging 
provides a useful way to track and determine the pharmacodynamics of drugs without altering its 
properties. 
 
Figure 7. Orthogonal view reconstructions of depth-stack images of mouse ileum samples using contrast from 
TPF (red), SHG (blue) and epi-CARS tuned to 2100 cm-1 (green). This sample was harvested 120 minutes after 
oral dosing with dGCPQ6 and imaged from the external surface inwards. Particles (arrowed) are seen at the 
boundary between the muscularis propria and the Brunner’s glands. Bile salts (BS) and erythrocytes (RBC) are 
marked for clarity. Image from reference (92). Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced 
with permission. 
Drug sensitivity is a major contributor for the prognosis of a disease with many tumours acquiring 
resistance to certain chemotherapeutic drugs (132). Using label-free CARS set to identify the cell 
nucleus (1096 cm-1), TPEF was utilised to distinguish perinuclear distribution of inherent fluorescent 
doxorubicin around chemo-resistant MCF-7 cells (133). Targeting of individual drugs themselves 
using distinct vibrational peaks not present in high concentration within cells can alleviate the need 
for isotopes. The drug fluorouracil has distinct peaks for C-F vibrational modes (e.g. 637 cm-1)
allowing one to identify its transformation in skin using Raman spectroscopy (134). A study to 
determine the distribution and drug release rate of paclitaxel from polymer compounds utilised 
CARS imaging directly for the unmodified drug. Through imaging at 3060 cm-1 for a paclitaxel 
vibrational mode, the in vivo biocompatibility of drug polymer based stents was determined to 
deliver drugs to the artery (135). Using peaks of increased intensity compared to that present in the 
surrounding tissue, its capability to produce contrast to identify the drug localisation has been 
demonstrated (136). These studies clearly indicate that label-free tracking of drugs is advancing 
dramatically and that many studies for their localisation and efficiency will increase with this 
advancement. 
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5 Scope and Challenges 
Among the available coherent Raman techniques, CARS is the most mature for translation to 
biomedical investigations and clinical studies. Its label-free, high resolution and chemical specific 
nature has allowed CARS to develop a niche for imaging lipids in biomedical studies with distinct 
advantages over conventional techniques such as mass spectrometry. Although non-resonant 
background observed in CARS imaging can lower signal to noise but efficient removal techniques are 
available and in certain cases this non-resonant background can be advantageous for viewing 
biological samples. 
 
Furthermore CARS can be easily used as a powerful tool for application within histopathology 
departments for improved clinical evaluation. For example, CARS imaging is increasingly being 
utilised to uncover mechanistic and morphological information in plaque formation. Ultimately, a 
multimodal system with a compilation of other non-invasive techniques for various conditions and 
diseases such as atherosclerosis could provide highly detailed information for early stage diagnosis 
and formation of plaques (137, 138). 
 
The ultimate challenge is the application of CARS during in vivo clinical procedures such as 
laparoscopy for on-site minimally invasive tissue diagnosis (139). The progression of this is hindered 
by challenges in the development of fibre based probes including those for endoscopy applications 
currently a prominent area of research in this field (139, 140). In general, successful application of 
CARS during such in vivo, clinical and surgical applications also critically rests on the development of 
robust, portable and low-cost lasers. Such a system requires the capability to deliver two ultrafast 
pulsed trains, effective signal collection of the backscattered CARS signal and adaption of a rapid 
scanning mechanism for an endoscopy approach (139, 140) along with a small foot-print fiber laser 
source (56, 57). Imaging techniques for motion reduction similar to that described for live animal 
myelin histomorphometry (141) will also assume importance for in vivo and clinical applications. 
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